- Home
- IPAR vs FOLD Comparison
IPAR vs FOLD Comparison
Compare IPAR & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPAR
- FOLD
- Stock Information
- Founded
- IPAR 1982
- FOLD 2002
- Country
- IPAR United States
- FOLD United States
- Employees
- IPAR N/A
- FOLD N/A
- Industry
- IPAR Package Goods/Cosmetics
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- IPAR Consumer Discretionary
- FOLD Health Care
- Exchange
- IPAR Nasdaq
- FOLD Nasdaq
- Market Cap
- IPAR 3.1B
- FOLD 2.5B
- IPO Year
- IPAR 1988
- FOLD 2007
- Fundamental
- Price
- IPAR $95.91
- FOLD $8.75
- Analyst Decision
- IPAR Strong Buy
- FOLD Strong Buy
- Analyst Count
- IPAR 5
- FOLD 8
- Target Price
- IPAR $154.60
- FOLD $27.88
- AVG Volume (30 Days)
- IPAR 247.8K
- FOLD 5.1M
- Earning Date
- IPAR 11-05-2025
- FOLD 11-04-2025
- Dividend Yield
- IPAR 3.34%
- FOLD N/A
- EPS Growth
- IPAR 14.29
- FOLD N/A
- EPS
- IPAR 5.02
- FOLD N/A
- Revenue
- IPAR $1,458,888,000.00
- FOLD $571,160,000.00
- Revenue This Year
- IPAR $4.18
- FOLD $21.12
- Revenue Next Year
- IPAR $5.35
- FOLD $21.23
- P/E Ratio
- IPAR $19.11
- FOLD N/A
- Revenue Growth
- IPAR 7.04
- FOLD 25.35
- 52 Week Low
- IPAR $91.06
- FOLD $5.51
- 52 Week High
- IPAR $148.15
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- IPAR 39.99
- FOLD 60.55
- Support Level
- IPAR $91.06
- FOLD $8.33
- Resistance Level
- IPAR $100.73
- FOLD $9.08
- Average True Range (ATR)
- IPAR 2.66
- FOLD 0.29
- MACD
- IPAR 0.71
- FOLD 0.04
- Stochastic Oscillator
- IPAR 50.16
- FOLD 72.73
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.